TCRR
TCR2 Therapeutics Inc. Common Stock
TCRR
TCRR
Delisted
TCRR was delisted on the 31st of May, 2023.
80 hedge funds and large institutions have $45M invested in TCR2 Therapeutics Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 15 increasing their positions, 29 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
48% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 29
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
80
Holding in Top 10
1
Calls
$1.14M
Puts
$429K
Top Buyers
| 1 | +$1.48M | |
| 2 | +$354K | |
| 3 | +$254K | |
| 4 |
TCM
Tang Capital Management
San Diego,
California
|
+$180K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$178K |
Top Sellers
| 1 | -$762K | |
| 2 | -$514K | |
| 3 | -$314K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$297K |
| 5 |
NM
Newtyn Management
New York
|
-$167K |